Profiles of testosterone and pre-androgens and sexual function in premenopausal women
The Journal of Sexual Medicine · 2025
DOI: 10.1093/jsxmed/qdae195 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2025. Verfasst von Marlene A Werner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sexology and Psychosomatic Gynaecology and Obstetrics, Amsterdam UMC, University of Amsterdam, Amsterdam Reproduction and Development, Cancer Center …. Hauptthemen laut MEDLINE: Testosterone, Premenopause, Dehydroepiandrosterone, Androstenedione. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Grollo-Ruzzene Foundation.
Abstract (Originalsprache)
Background
There is inconsistent evidence as to the role of testosterone and pre-androgens in premenopausal female sexual function, and reported associations between blood concentrations of these hormones and female sexual function vary in strength.
Aim
To examine the patterns of testosterone and pre-androgen concentrations and variations in sexual function in premenopausal eumenorrheic women.
Methods
This was a secondary analysis of a sample of 588 premenopausal eumenorrheic women from the Grollo-Ruzzene Foundation Young Women’s Health Study. Socio-demographics, health information, and questionnaire data were collected using online surveys. Eligible women were invited to provide a blood sample. We ran latent profile analysis (LPA) and subsequent analyses in R using RStudio. Outcomes Indicator variables in the LPA included sexual arousal and desire domains of the Profile of Female Sexual Function and testosterone, dehydroepiandrosterone (DHEA), and androstenedione, measured by liquid chromatography–tandem mass spectrometry.
Results
Analyses resulted in a pattern of 3 latent classes. Classes reporting relatively lower and higher sexual arousal (LPA-derived means and 95% CIs: -0.79 [-1.24; -0.34] and 0.62 [0.51; 0.72]) did not differ significantly in sex steroid concentrations (testosterone: -0.21 [-0.38; -0.03] and -0.33 [-0.47; -0.20]; DHEA: -0.47 [-0.57; -0.37] and -0.26 [-0.39; -0.13]; androstenedione: -0.36 [-0.50; -0.22] and -0.39 [-0.49; -0.29]), while the class reporting relatively medium arousal (-0.11 [-0.31; 0.08]) showed the highest testosterone, DHEA, and androstenedione concentrations (testosterone: 0.8 [0.60; 1.01]; DHEA: 0.99 [0.76; 1.23]; androstenedione: 1.08 [0.88; 1.29]). There were no significant differences in sexual desire between classes (-0.08 [-0.23; 0.06]; 0.00 [-0.13; 0.14]; 0.10 [-0.09; 0.30]) differing significantly in sex steroid concentrations (-0.69 [-0.80; -0.58], -0.04 [-0.15; 0.07], 0.94 [0.71; 1.16] for testosterone) nor associations between the sex steroid concentrations and degrees of sexual desire. Clinical Implications These findings cast further doubt on the utility of measuring sex steroids for diagnosing female sexual dysfunction in premenopausal eumenorrheic women, even when considered in combination. Strengths and Limitations We analyzed a large community sample and controlled for potentially biasing factors. We analyzed sex steroid concentrations determined with gold-standard methodology. Excluding women with early menopause and menstrual dysfunction might have resulted in finding 3, rather than more, latent classes.
Conclusion
Testosterone and pre-androgen profiles do not clearly identify premenopausal eumenorrheic women with low sexual arousal and desire.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sexology and Psychosomatic Gynaecology and Obstetrics, Amsterdam UMC, University of Amsterdam, Amsterdam Reproduction and Development, Cancer Center Amsterdam, Amsterdam 1105 AZ, The Netherlands.
- Department of Methodology and Statistics, Tilburg University, Tilburg, The Netherlands.
- Women's Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia.
- Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria 3004, Australia.
ORCID-Profile: Marlene A Werner, Caspar J Van Lissa, Stephanie Both, Marina A Skiba, Robin J Bell, Susan R Davis
Förderung
- Grollo-Ruzzene Foundation
Zitieren
APA
Werner, M. A., Van Lissa, C. J., Both, S., Skiba, M. A., Bell, R. J., & Davis, S. R. (2025). Profiles of testosterone and pre-androgens and sexual function in premenopausal women. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdae195
Vancouver
Werner MA, Van Lissa CJ, Both S, Skiba MA, Bell RJ, Davis SR. Profiles of testosterone and pre-androgens and sexual function in premenopausal women. The Journal of Sexual Medicine. 2025. doi:10.1093/jsxmed/qdae195
BibTeX
@article{Werner2025,
author = {Werner, Marlene A and Van Lissa, Caspar J and Both, Stephanie and Skiba, Marina A and Bell, Robin J and Davis, Susan R},
title = {Profiles of testosterone and pre-androgens and sexual function in premenopausal women},
journal = {The Journal of Sexual Medicine},
year = {2025},
doi = {10.1093/jsxmed/qdae195}
}
EUVIMED